152 related articles for article (PubMed ID: 11370534)
21. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
[TBL] [Abstract][Full Text] [Related]
22. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.
Lemoine NR; Mayall ES; Wyllie FS; Williams ED; Goyns M; Stringer B; Wynford-Thomas D
Oncogene; 1989 Feb; 4(2):159-64. PubMed ID: 2648253
[TBL] [Abstract][Full Text] [Related]
23. [Somatic genetics of breast cancer].
Bièche I; Lidereau R
Bull Cancer; 1997 Jan; 84(1):83-96. PubMed ID: 9180865
[TBL] [Abstract][Full Text] [Related]
24. [Molecular pathways of pancreatic carcinogenesis].
Torrisani J; Buscail L
Ann Pathol; 2002 Oct; 22(5):349-55. PubMed ID: 12483152
[TBL] [Abstract][Full Text] [Related]
25. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
26. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
27. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
Zitzelsberger H; Thomas G; Unger K
Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
[TBL] [Abstract][Full Text] [Related]
29. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
Aldred MA; Ginn-Pease ME; Morrison CD; Popkie AP; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang SM; Plass C; Eng C
Cancer Res; 2003 Jun; 63(11):2864-71. PubMed ID: 12782592
[TBL] [Abstract][Full Text] [Related]
30. [Biology of solid cancers: breast cancer as an example. First part: genetic systems implicated in carcinogenesis].
Bièche I; Lidereau R
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):131-41. PubMed ID: 8690861
[TBL] [Abstract][Full Text] [Related]
31. [Cell cycle and carcinogenesis].
Solé Balcells F
Ann Urol (Paris); 1995; 29(5):271-9. PubMed ID: 8638907
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetics of thyroid tumors and surgical decision-making.
Learoyd DL; Messina M; Zedenius J; Robinson BG
World J Surg; 2000 Aug; 24(8):923-33. PubMed ID: 10865036
[TBL] [Abstract][Full Text] [Related]
33. Thyrotropin receptor: a role for thyroid tumourigenesis?
Russo D; Arturi F; Chiefari E; Filetti S
Forum (Genova); 1999; 9(2):166-75. PubMed ID: 10385711
[TBL] [Abstract][Full Text] [Related]
34. [From the cytogenetics to the cytogenomics of thyroid tumors].
Perissel B; Bernheim A; Couturier J; Fouilhoux G; Vago P
Bull Cancer; 2002 Jun; 89(6):588-92. PubMed ID: 12135859
[TBL] [Abstract][Full Text] [Related]
35. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
36. [Identification of oncogenes and anti-oncogenes].
Thomas G
Pathol Biol (Paris); 1995 Mar; 43(3):143-9. PubMed ID: 7675540
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
38. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
39. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.
Sandrini F; Matyakhina L; Sarlis NJ; Kirschner LS; Farmakidis C; Gimm O; Stratakis CA
Genes Chromosomes Cancer; 2002 Oct; 35(2):182-92. PubMed ID: 12203783
[TBL] [Abstract][Full Text] [Related]
40. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
